Cantargia Reports Timelines for Nadunolimab Clinical Trials in Leukemia and Triple Negative Breast Cancer
LUND, SE / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported currently...
LUND, SE / ACCESSWIRE / August 27, 2024 / Cantargia (STO:CANTA) Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported currently...
PALO ALTO, CA / ACCESSWIRE / August 27, 2024 / Bioz, Inc. a leader in AI-powered research solutions, is excited...
LUND, SE / ACCESSWIRE / August 27, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F) Spago Nanomedical AB (publ) today announced that the...
Fujitsu forms strategic partnership with Paradigm and will provide offerings that leverage the power of AI TOKYO, Aug. 26, 2024...